Legal and ethical considerations in the transfusion of infected or untested autologous blood

American Journal of Clinical Pathology

Volumn 128, Issue 1, 2007, Pages 135-142

  Brooks, Jay P ^a,c   Ferrell, Joan E ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b University of Oklahoma Medical Center   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Autologous transfusion; Ethics; Infected; Legal

Indexed keywords

BACTEREMIA; BLOOD AUTOTRANSFUSION; BLOOD BANK; CREUTZFELDT JAKOB DISEASE; ETHICS; GEOGRAPHIC DISTRIBUTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION; LAW; LEGAL ASPECT; PHYSICIAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TORQUE TENO VIRUS; TRANSFUSION RELATED ACUTE LUNG INJURY; ARTICLE; BLOOD STORAGE; BLOODBORNE BACTERIUM; DISEASE TRANSMISSION; MEDICOLEGAL ASPECT;

BLOOD BANKS; BLOOD PRESERVATION; BLOOD TRANSFUSION, AUTOLOGOUS; BLOOD-BORNE PATHOGENS; HUMANS; INFECTION; LEGISLATION, MEDICAL;

EID: 34547122886     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/5T6Q2XUL1C6J5U4D     Document Type: Review

References (54)

1. Yomtovian R, Ceynar J, Kepner JL, et al. Predeposit autologous blood transfusion: an analysis of donor attitudes and attributes. Qual Rev Bull. 1987;13:45-50.
2. Busch MP, Young MJ, Samsom SM, et al, for the Transfusion Safety Study Group. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions prior to the implementation of HIV-1 antibody screening. Transfusion. 1991;31:4-11.
3. Moltzan C, Proulx N, Bormanis J, et al. Perceptions and motivations of Canadian autologous blood donors. Transfus Med. 2001;11:177-182.
4. Lee SJ, Liljas B, Churchill WH, et al. Perceptions and preferences of autologous blood donors. Transfusion. 1998;38:757-763.
5. Graham ID, Fergusson D, Dokainish H, et al. Autologous versus allogeneic transfusion: patients' perceptions and experiences. CMAJ. 1999;160:989-995.
6. Banning M, Bormanis J, Lander N, et al. Current perceptions of Canadian autologous blood donors. Vox Sang. 2006;91:157-161.
7. Goodnough LT, Monk TG. Blood conservation in patients undergoing non-cardiac surgery. Curr Opin Anaesthesiol. 2000;13:365-370.
8. Brecher ME, Goodnough LT. The rise and fall of preoperative autologous blood donation. Transfusion. 2002;42:1618-1622.
9. Schved JF. Preoperative autologous blood donation: a therapy that needs to be scientifically evaluated. Transfus Clin Biol. 2005;12:365-369.
10. Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion. 2003;43:668-676.
11. Duguid JK. Review: autologous blood transfusion. Clin Lab Haematol. 1999;21:371-376.
12. Park WP, Chandhok D. Transfusion-associated complications. Int Anesthesiol Clin. 2004;42:11-26.
13. Klein HG. Transfusion safety: avoiding unnecessary bloodshed. Mayo Clin Proc. 2000;75:5-7.
14. Linden JV, Wagner K, Voytovich AE, et al. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion. 2000;40:1207-1213.
15. Shulman IA, Osby M. Storage and transfusion of infected autologous blood or components: a survey of North American laboratories. Arch Pathol Lab Med. 2005;129:981-983.
16. America's Blood Supply in the Aftermath of September 11, 2001: Hearing Before the Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce, 107th Cong, 56 (2002) (statement of Lawrence T. Goodnough, vice president, Society for the Advancement of Blood Management). Available at http://energycommerce.house.gov/reparchives/107/action/107-137.pdf [Table 3]. Accessed May 8, 2007.
17. Goldman M, Rémy-Prince S, Trépanier A, et al. Autologous donation error rates in Canada. Transfusion. 1997;37:523-527.
18. Ohto H, Fuji T, Wakimoto N, et al. A survey of autologous blood collection and transfusion in Japan in 1997. Transfus Sci. 2000;22:13-18.
19. Linden JV. Autologous blood errors and incidents [abstract]. Transfusion. 1994;34(suppl):28S.
20. Linden JV. Errors in transfusion medicine: scope of the problem. Arch Pathol Lab Med. 1999;123:563-565.
21. Sazama K. Reports of 355 transfusion associated deaths: 1976 through 1985. Transfusion. 1990;30:583-590.
22. Williamson LM, Lowe S, Love EM, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. Br Med J. 1999;319:16-19.
23. Pub L No. 101-336, 104 Stat 327 (codified at 42 USC §12101-12213).
24. American Association of Blood Banks. The ADA, HIV, and Autologous Blood Donation. Bethesda, MD: AABB; 1998. Association bulletin 98-5. Available at http://www.aabb.org/Content/Members_Area/Association_Bulletins/ ab98-5.htm. Accessed May 8, 2007.
25. American Association of Blood Banks. 5.4-4 Autologous donor qualification. Standards Source. 2006. Available at http://www.aabb.org/ Documents/Newsletters_and_Journal/AABB_Standards_Source/ Standards%20Source%20Issues/ss06-04c.pdf. Accessed May 8, 2007.
26. Bragdon v Abbott, 118 US 2196 (1998).
27. Abbott v Bragdon, 163 F3d 87, 89-90 (1st Cir 1998).
28. Shulman-Cutler S. The AABB's autologous blood donation suggested guidance: autologous blood, HIV, and the Americans with Disabilities Act. Jurimetrics J. 2006;46:407.
29. Ariz Rev Stat §32-1403.
30. Ariz Rev Stat §32-1803.
31. Cal Health & Safety Code §1645.
32. Cal Health & Safety Code §1603.1.
33. Cal Health & Safety Code §1621.5.
34. Fla Stat §381.0604.
35. Ill §693.140.
36. Ind Code 16-41-12.
37. Ky Rev Stat §214.456.
38. La Rev Stat 40:1299.147.
39. Mich Comp Laws §333.9123.
40. NJ Stat §26:2A-14.
41. NJ Stat §26:2A-15.
42. Ohio Rev Code Ann 3701.246.
43. 63 Okla Stat §2167.1.
44. Tenn Code Ann §68-32-102.
45. W Va Code §16-3C-9.
46. Wis Stat §252.13.
47. Dodd RY, Notari EP IV, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975-979.
48. Lee SJ, Liljas B, Neumann PJ, et al. The impact of risk information on patients' willingness to pay for autologous blood donation. Med Care. 1998;36:1162-1173.
49. Sazama K. Managing infectious or untested autologous blood components: the ethical dilemma of private rights versus public safety. Arch Pathol Lab Med. 2005;129:1212-1213.
50. Brooks JP. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products. Transfusion. 2005;45(4 suppl):159S-171S.
51. Koshy R. Navigating the information technology highway: computer solutions to reduce errors and enhance patient safety. Transfusion. 2005;45(4 suppl):189S-205S.
52. Shulman IA. Testing blood donors for communicable diseases. AJCP News. Feb 15, 2006. Available at http://www.ajcp.com/headlines/news/ 200603151.html. Accessed May 8, 2007.
53. Commission Directive 2004/33, Annex III, 2004 O.J. (L 91) 25, 34 (EC).
54. British Committee for Standards in Haematology Blood Transfusion Task Force. Guidelines for autologous transfusion, I: pre-operative autologous donation. Transfus Med. 1993;3:307-316.